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Introduction
Vesicle traffi  c from the ER to the Golgi complex is mediated by 
the sequential action of the COPII and COPI coat protein com-
plexes (Aridor et al., 1995; Presley et al., 1997; Scales et al., 
1997). COPII (coat protein II) vesicles form at the transitional 
ER (tER), which is a specialized subdomain of the ER that is 
distinct from the rough ER (Bannykh et al., 1996). These vesi-
cles may tether and fuse to each other (homotypic fusion) to 
form the vesicular tubular clusters (VTCs), which is a pre-Golgi 
structure (also called the intermediate compartment) that lies 
adjacent to the tER (Aridor et al., 1995; Presley et al., 1997; 
Scales et al., 1997; Stephens et al., 2000; Xu and Hay, 2004). 
COPI (coat protein I) is then recruited onto VTCs before coated 
structures move cargo to the Golgi apparatus (Presley et al., 
1997; Scales et al., 1997; Ben-Tekaya et al., 2005; Sannerud 
et al., 2006). Although components of the ER–Golgi traffi  cking 
machinery are highly conserved from yeast to man (Ferro-
Novick and Jahn, 1994), no equivalent to a pre-Golgi compart-
ment has been identifi  ed in the yeast Saccharomyces cerevisiae. 
COPII vesicle tethering/fusion has been reconstituted in vitro 
with yeast membrane fractions (Barlowe, 1997; Barrowman 
et al., 2000). However, in these assays, vesicles released from 
the ER in vitro are thought to fuse with Golgi membranes 
( heterotypic  fusion).
Tethering factors have been proposed to mediate the ini-
tial interaction of a transport vesicle with its acceptor compart-
ment and are implicated in maintaining the identity of organelles 
(Whyte and Munro, 2002). Tethers are either large oligomeric 
complexes or long coiled-coil proteins that activate or act down-
stream of the GTPases (Rabs) that regulate membrane traffi  c 
(Pfeffer, 1999; Whyte and Munro, 2002; Sztul and Lupashin, 
2006). Most peripherally associate with membranes and are re-
cruited directly onto the compartment on which they function 
(Whyte and Munro, 2002). Although many tethers have been 
identifi  ed, the mechanism of vesicle tethering has remained 
  elusive. To address questions concerning the specifi  city of vesicle 
traffi  c and organelle identity, we have chosen to focus our stud-
ies on the tether called TRAPP. The 10 subunits of TRAPP were 
initially identifi  ed in the yeast S. cerevisiae (Sacher et al., 1998, 
2000). TRAPP subunits are found in two complexes (TRAPPI 
and TRAPPII) that act at different stages of membrane traffi  c. 
TRAPPI acts in ER–Golgi traffi  c, whereas TRAPPII is required 
for traffi  c through the early endosome (Sacher et al., 2001; 
Cai et al., 2005).
Bet3p, which is the most highly conserved TRAPP 
component, is 54% identical to its mammalian counterpart 
and stably localizes to Golgi membranes (Sacher et al., 1998; 
  Barrowman et al., 2000). In yeast, the temperature-sensitive 
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RAPPI is a large complex that mediates the tethering 
of COPII vesicles to the Golgi (heterotypic tethering) 
in the yeast Saccharomyces cerevisiae. In mamma-
lian cells, COPII vesicles derived from the transitional 
  endoplasmic reticulum (tER) do not tether directly to the 
Golgi, instead, they appear to tether to each other (homo-
typic tethering) to form vesicular tubular clusters (VTCs). 
We show that mammalian Bet3p (mBet3p), which is the 
most highly conserved TRAPP subunit, resides on the tER 
and adjacent VTCs. The inactivation of mBet3p results in 
the accumulation of cargo in membranes that colocalize 
with the COPII coat. Furthermore, using an assay that re-
constitutes VTC biogenesis in vitro, we demonstrate that 
mBet3p is required for the tethering and fusion of COPII 
vesicles to each other. Consistent with the proposal that 
mBet3p is required for VTC biogenesis, we ﬁ  nd  that 
ERGIC-53 (VTC marker) and Golgi architecture are 
  disrupted in siRNA-treated mBet3p-depleted cells. These 
ﬁ   ndings imply that the TRAPPI complex is essential for 
VTC biogenesis.
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bet3-1 mutant blocks ER–Golgi traffi  c at 37°C (Rossi et al., 
1995). Although mammalian Bet3p (mBet3p) has been shown 
to act in ER–Golgi traffi  c after COPII vesicle budding and 
before Rab1, it is unknown if it participates in VTC biogen-
esis (Loh et al., 2005). We show that mBet3p is enriched at 
the tER and adjacent VTCs. Microinjected α-mBet3p results 
in the accumulation of cargo in structures that colocalize with 
the COPII coat. Furthermore, the inactivation of mBet3p blocks 
homotypic COPII vesicle tethering in vitro. These fi  ndings im-
ply that mBet3p mediates the biogenesis of VTCs by linking 
COPII vesicles to each other.
Results
The localization of mBet3p is resistant 
to brefeldin A (BFA)
Previous studies identifi  ed a cytosolic pool of mBet3p (Sacher 
et al., 2000; Loh et al., 2005). However, the enrichment of this 
protein to a particular intracellular structure was not demon-
strated in these studies. To begin to address the role of mBet3p 
in VTC biogenesis, we prepared polyclonal antibodies to this 
TRAPP subunit to determine the intracellular compartment 
where mBet3p resides.
Immunofl   uorescence microscopy revealed that mBet3p 
localizes to punctate structures in the perinuclear region of 
COS-7 cells (Fig. 1 A). This localization was not observed when 
antibody was pretreated to a nitrocellulose strip containing 
Figure 1.  mBet3p partially colocalizes with markers of the pre-Golgi 
compartment. (A) Anti-mBet3p antibody speciﬁ  cally recognizes mBet3p. 
Afﬁ  nity-puriﬁ  ed α-mBet3p was mock treated, or pretreated with His6-mBet3p 
(mBet3p depleted). The antibody was then used to label endogenous 
mBet3p in COS-7 cells by indirect immunoﬂ  uorescence. Nuclei were identi-
ﬁ  ed by DAPI staining. (B) Colocalization of endogenous mBet3p (red im-
ages) with ERGIC-53 (top, green) and COPI (bottom, green) to pre-Golgi 
and Golgi membranes in BSC-1 cells. See merged image on right. The in-
sets are magniﬁ  ed in the next row. Bars, 10 μm. 
Figure 2.  The localization of mBet3p is largely resistant to BFA. NRK cells 
were treated with 5 μg/ml BFA for 1 h, and the localization of mBet3p 
(left), COPI (top right), and Man II (bottom right) were determined by indi-
rect immunoﬂ  uorescence. Bars, 10 μm. COPII VESICLE TETHERING • YU ET AL. 361
  immobilized recombinant mBet3p (Fig. 1 A). In HeLa cells, the 
localization of mBet3p was predominantly cytosolic.   However, 
when the cytosolic pool of mBet3p was removed by   digitonin 
before fi   xation, its perinuclear localization was revealed 
  (unpublished data). The perinuclear localization of mBet3p 
was also observed in several other mammalian cell lines, in-
cluding BSC-1 (Fig. 1 B) and NRK cells (Fig. 2). mBet3p was 
largely found adjacent to ERGIC-53, which is a marker for the 
pre-Golgi compartment (Schweizer et al., 1988), and COPI 
(Fig. 1 B). COPI is a heptameric coat complex that is recruited 
to pre-Golgi and early Golgi structures (Oprins et al., 1993). 
 Interestingly,  by  immunofl  uorescence, mBet3p has a punctate 
appearance rather than a continuous ribbonlike pattern, which 
is typical of Golgi proteins.
Although the Golgi disassembles in the presence of the 
drug BFA, we found that, surprisingly, the localization of 
mBet3p was largely resistant to BFA (Fig. 2, top and bottom). 
The observation that the localization of a component of a COPII 
tethering complex is resistant to BFA prompted us to examine if 
mBet3p is associated with the tER. The tER is a BFA-resistant 
subdomain of the ER that specializes in the formation of   COPII 
vesicles (Saraste and Svensson, 1991; Bannykh et al., 1996; 
Ward et al., 2001). As a marker for the tER we used Sec31p, 
which is a subunit of the COPII coat (Barlowe et al., 1994). 
Sec31p-labeled structures were most abundant in the vicinity 
of the Golgi apparatus and largely colocalized with mBet3p 
(Fig. 3 A and Fig. S1, available at http://www.jcb.org/cgi/
content/full/jcb.200603044/DC1). 
mBet3p appears to be recruited 
to the tER region
To address the relationship of mBet3p to the tER, we asked if 
the localization of mBet3p was perturbed by conditions that 
are known to disrupt or alter tER sites. When cells are treated 
with the microtubule-disrupting agent nocodazole, the tER dis-
perses and tER sites cluster near Golgi fragments (Hammond 
and Glick, 2000). Although the cytosolic pool of mBet3p 
  appeared to increase in the presence of nocodazole, mBet3p 
largely remained associated with the tER (Fig. 3 B, top) and 
clustered near the Golgi marker GM130 (Fig. 3 B, bottom). 
The colocalization of mBet3p with the tER marker Sec31p 
is illustrated in Video 1 (available at http://www.jcb.org/cgi/
content/full/jcb.200603044/DC1), which is a 3D reconstruction 
of confocal images obtained from serial sections. To determine 
if the localization of mBet3p is changed by other conditions that 
are known to alter the localization of the tER, we microinjected 
Sar1p H79G into cells. Sar1p H79G is the constitutively ac-
tive GTP-bound form of Sar1p that blocks export from the ER 
(Kuge et al., 1994). In cells expressing Sar1p H79G, ER exit 
sites have been shown to cluster (Ward et al., 2001). Golgi gly-
cosylation enzymes like mannosidase II (Man II) are recycled 
back to the ER (Seemann et al., 2000a), whereas the localization 
of the golgin GM130 remains unchanged (Fig. 3 C; Miles et al., 
2001; Ward et al., 2001). Unlike Man II and GM130, mBet3p 
always clustered with the ER exit sites (Fig. 3 C).
Together, these fi  ndings imply that mBet3p is recruited to 
membranes at or near the tER. Like Sec31p, its localization is 
Figure 3.  The localization of mBet3p is disrupted by reagents that are known to disrupt the tER. (A) The localization of mBet3p (left, red) largely overlaps 
(Merge) with Sec31p (middle, green) in BSC-1 cells. The insets are magniﬁ  ed on the bottom right. (B) BSC-1 cells, treated for 1 h with 10 μg/ml no-
codazole, were ﬁ  xed and stained with antibodies directed against mBet3p (red) and Sec31p (top, green), and mBet3p (red) and GM130 (bottom, green). 
The insets are magniﬁ  ed on the right. (C) The localization of mBet3p clusters in response to microinjected Sar1p H79G, which is a GTP-locked mutant. NRK 
cells were microinjected with 1.5 mg/ml Sar1p H79G. mBet3p (top), Man II (middle), and GM130 (bottom) were visualized by indirect   immunoﬂ  uorescence. 
All injected cells are marked with an asterisk. Bars, 10 μm.JCB • VOLUME 174 • NUMBER 3 • 2006  362
resistant to BFA and sensitive to reagents that block export from 
the ER or disrupt tER sites. To more precisely determine the lo-
calization of mBet3p, immuno-EM was performed. For this 
analysis, the tER was defi  ned as a cluster of Sec31p-labeled 
(large gold particles) membranes. Immuno-EM demonstrated 
that COPII vesicles and COPII budding profi   les (Fig. 4 A, 
  arrow) contained mBet3p (small gold particles). The observed 
localization of mBet3p to the tER was signifi  cant, as quantitation 
revealed that the labeling density of mBet3p at the tER was 
7.6–22 times higher than the labeling density of mBet3p over 
the ER and other organelles (Fig. 4 B). Although no signifi  cant 
labeling was observed on Golgi cisternae (Fig. 4 B), mBet3p 
was found on tubules with a dense lumen in proximity to multi-
vesicular bodies (MVBs). Some of these tubules were con-
nected to MVBs (Fig. 4 B and Fig. S2 A, available at http://www.
jcb.org/cgi/content/full/jcb.200603044/DC1). This observation 
is consistent with the fi  nding that there is more than one pool of 
mBet3p (Sacher et al., 2001; Loh et al., 2005). It is also consis-
tent with our recent fi  nding that the yeast TRAPPII complex, 
which also contains Bet3p, localizes to the early endosome 
(Cai et al., 2005).
mBet3p is required for COPII vesicle 
coisolation in vitro
In vitro transport studies have shown that mBet3p acts after 
COPII vesicle budding, but before the GTPase Rab1 (Loh 
et al., 2005). However, the role of mBet3p in VTC biogenesis 
was not addressed in these earlier studies. Homotypic COPII 
vesicle tethering and fusion have recently been reconstituted 
in vitro (Xu and Hay, 2004). Using this in vitro assay, we di-
rectly addressed whether mBet3p is required for the inter-
action of COPII vesicles with each other. For this experiment, 
COPII vesicle populations that were marked in two different 
ways were generated from permeabilized cells. One popula-
tion of vesicles contained Myc-tagged temperature-sensitive 
vesicular stomatitis virus glycoprotein (ts045 VSV-Myc), and a 
second population of vesicles contained untagged radiolabeled 
VSV-G* (Fig. 5 A). After the vesicles were formed in a fi  rst-
stage incubation, the permeabilized donor cells were removed 
and the differently marked vesicle populations were combined 
and incubated together in a second-stage incubation in the pres-
ence of cytosol and an ATP-regenerating system. VSV-G*–
  containing radiolabeled vesicles that interact with VSV-G–Myc 
vesicles were coisolated from the supernatant with anti-Myc 
antibody and detected by autoradiography. When the vesicles 
fused, heterotrimeric VSV-G that contained both VSV-G–Myc 
and VSV-G* was formed and detected by immunoprecipitation 
in the presence of detergent (Xu and Hay, 2004). Interestingly, 
α-mBet3p, but not control IgG, inhibited the coisolation of ves-
icles and their fusion when added to the second-stage incuba-
tion (Fig. 5 B). Furthermore, this inhibition was completely 
reversed when the antibody was added in the presence of excess 
recombinant His6-mBet3p (Fig. S2 B). In contrast, antibody di-
rected against the ER–Golgi SNARE syntaxin-5 inhibited the 
fusion of COPII vesicles without dramatically affecting their 
coisolation (Fig. 5 B). In support of the proposal that mBet3p 
mediates homotypic COPII vesicle tethering, Western blot ana  l-
ysis revealed the presence of mBet3p on the reaction product 
(Fig. 5 C,   bottom), nascent VTCs that also contained VSV-G–
Myc (Fig. 5 C, top). The localization of mBet3p to nascent 
VTCs was specifi  c, as mBet3p was not present on the untagged 
control or when vesicle budding was blocked with the GDP-
locked form of Sar1 (Fig. 5 C, bottom).
A single-stage transport assay was also performed in the 
presence of α-mBet3p and vesicle release was monitored from 
the permeabilized cells. In this experiment, α-mBet3p was 
added to the cells in vitro before vesicles were formed. Studies in 
Figure 4.  mBet3p is enriched at the tER and adjacent pre-Golgi 
  membranes. (A) Immuno-EM in NRK cells conﬁ  rmed that mBet3p (5-nm gold 
particles) resides on the tER region labeled with Sec31p (10-nm gold 
  particles). The arrow points to a COPII vesicle containing mBet3p. Bar, 
100 nm. (B) mBet3p resides on the tER, and not ER, membranes (see 
  Materials and methods for a description of the quantitation). NE, nuclear 
envelope; PM, plasma membrane; mito, mitochondrial outer membrane; 
Golgi, Golgi cisternae; endo, endosomal structures.COPII VESICLE TETHERING • YU ET AL. 363
both mammalian cells and yeast have previously demonstrated 
that blocking the consumption of COPII vesicles increases 
their release from permeabilized cells in vitro (Barlowe, 1997; 
Xu and Hay, 2004). Consistent with the fi  nding that   COPII 
  vesicles fail to fuse when mBet3p is inactivated, we observed 
that α-mBet3p stimulated the release of vesicles from the cells 
(Fig. 5 D). This fi  nding also demonstrates that mBet3p is not 
required for vesicle budding and is consistent with a previous 
study that showed α-mBet3p acts after COPII vesicles bud from 
the ER in vitro (Sacher et al., 1998; Loh et al., 2005).
Accumulated cargo colocalizes with 
Sec31p when mBet3p is inactivated in vivo
In vitro, α-mBet3p blocks the conversion of VSV-G from an 
endo H–sensitive ER form to an endo H–resistant Golgi form 
(Loh et al., 2005). However, the role of mBet3p in vivo has not 
been addressed. To determine where cargo accumulates when 
mBet3p is inactivated in vivo, we monitored the traffi  cking of 
two different marker proteins, tsO45 VSV-G and the plasma 
membrane marker CD8. One marker was used to quantitate the 
traffi  cking defect when α-mBet3p was injected into cells, and 
the other marker was used to address where cargo accumulates. 
Quantitation of tsO45 VSV-G transport in HeLa cells revealed 
that the inactivation of mBet3p resulted in a nearly 70% de-
crease in the traffi  cking of YFP-tagged tsO45 VSV-G to the cell 
surface (Fig. 6 A). 
To address where cargo accumulates when mBet3p is 
  inactivated, cDNA encoding CD8 was microinjected into the 
nuclei of BSC-1 cells. The CD8 mRNA was then allowed to 
  accumulate in the presence of cycloheximide before α-mBet3p, 
or control IgG, was microinjected (Fig. 6 B). After 1 h, the cy-
cloheximide was removed and CD8 was synthesized during a 
second incubation. Newly synthesized CD8 was then chased 
out of the ER during a fi  nal incubation in the presence of cyclo-
heximide (Pelletier et al., 2000). In control cells, CD8 was 
found at the cell surface and the perinuclear region of the cell 
(Fig. 6 B; IgG control). Perinuclear CD8 colocalized with 
  Golgin-84 in IgG injected cells (unpublished data). In the 
Figure 5.  mBet3p links COPII vesicles to each 
other.  (A) COPII vesicle coisolation in vitro. 
Vesicles marked in two different ways were 
released from permeabilized NRK cells dur-
ing the stage I incubation. During the stage 
II incubation, vesicles tethered to each other 
and subsequently fused. (B) Anti-Bet3p anti-
body blocks the coisolation of COPII vesicles. 
Two COPII vesicle populations were formed 
in vitro in a ﬁ   rst-stage incubation, as previ-
ously described (Xu and Hay, 2004). The two 
vesicle populations were then combined and 
preincubated together for 20 min on ice in the 
absence or presence of antibody. After the in-
cubation, one sample was kept on ice, while 
the other samples were incubated at 32°C for 
60 min in a second-stage incubation. 1, one 
population of vesicles was untagged instead of 
Myc-tagged; 2, incubated on ice for 60 min; 
3, complete reaction incubated without anti-
body; 4, contained α-mBet3p (168 nM;  5μg 
per reaction); 5, contained α-syntaxin-5 
(168 nM); 6, contained rabbit IgG (168 nM). 
(C) Bet3p is present on nascent VTCs formed 
in vitro. Stage I reactions were performed in 
the presence or absence of GDP-locked Sar1 
T39N. Lane 1, complete reaction; lane 2, 
complete reaction plus GDP-locked Sar1 T39N 
(800 nM); lane 3, vesicles were formed from 
NRK cells expressing untagged VSV-G. Vesicles 
released during stage I were then incu  bated in 
stage II (60 min at 32°C) and immuno  isolated 
with anti-Myc antibody. The ﬁ  nal immunoiso-
lates were subjected to Western blot analysis 
to detect mBet3p (bottom) and VSV-Myc (top). 
(D) Anti-Bet3p antibody stimulates the release 
of COPII vesicles from permeabilized cells 
when added during the stage I incubation. 
COPII vesicle populations were formed in vitro 
using permeabilized NRK cells as in B, only 
the incubation was performed for 90 min (as 
described in Fig. 1 A of Xu and Hay, 2004). 
The permeabilized cells were   removed by cen-
trifugation, and the released vesicles were im-
munoisolated with an antibody to the integral 
membrane protein p24. The VSV-G* in the precipitate was quantiﬁ  ed by autoradiography and reported as the percentage of the total VSV-G* in the 
starting cells. 1, complete reaction without antibody; 2, Sar1 T39N was included in the reaction at a concentration of 1 μM; 3, complete   reaction plus 
110 nM anti-mBet3 antibody. Error bars are the SEM.JCB • VOLUME 174 • NUMBER 3 • 2006  364
 presence  of  α-mBet3p, Golgin-84 localization was fragmented. 
This fi  nding is consistent with the observation that α-mBet3p 
disrupts the Golgi (see the next section). When mBet3p was in-
activated, CD8 accumulated in spots that surround the nucleus. 
These spots largely colocalized with Sec31p, but were adjacent 
to Golgin-84–containing membranes (Fig. 6 B), implying that 
cargo accumulates in membranes that contain the COPII coat. 
These results are also consistent with previous studies showing 
that α-mBet3p blocks the traffi  cking of VSV-G before it is con-
verted to an endo H–resistant form in the Golgi (Loh et al., 
2005). Thus, both in vitro and in vivo traffi  cking studies support 
the hypothesis that mBet3p is required for the interaction of 
COPII vesicles with each other.
tER sites disperse and Golgi architecture 
is disrupted by perturbation of mBet3p
We also determined the consequences of depleting mammalian 
cells of mBet3p by specifi  cally reducing its expression with 
siRNA. Two different siRNA duplexes were used for these stud-
ies, BetC (Fig. 7 A) and BetA (not depicted). Similar results were 
obtained with both siRNA duplexes. BetC, but not the control 
duplex (luciferase), reduced the expression of mBet3p (Fig. 7 A). 
The loss of mBet3p did not lead to a reduction of Sec31p or 
the ER protein ER60 (Fig. 7 A). However, the localization of 
Sec31p was dispersed, and its intense perinuclear localization, 
which marks the tER, was lost (Fig. 7 B). In addition, pre-Golgi 
and Golgi compartments were disrupted (Fig. 7 C and Fig. S2 C). 
The localization of β-tubulin, however, remained unaltered 
(Fig. S2 D). Similar effects on the Golgi were obtained when 
cells were micro-injected with α-mBet3p (Fig. S3, available at 
http://www.jcb.org/cgi/content/full/jcb.200603044/DC1).
EM analysis confi  rmed that the depletion of mBet3p dis-
rupts Golgi architecture (Fig. 7 D, compare the Golgi [G] in the 
top and bottom images), and leads to a dramatic accumulation 
of vesicles (Fig. 7 D, arrows). Although tER was diffi  cult 
to identify by EM in the siRNA-treated mBet3p-depleted 
cells, highly dilated rough ER was observed (Fig. S4, available 
at http://www.jcb.org/cgi/content/full/jcb.200603044/DC1). 
Quantifi  cation revealed a threefold decrease in the amount of 
membrane that represents Golgi cisternae. These fi  ndings pro-
vide in vivo evidence that mBet3p links COPII vesicles to each 
other at or near the tER, an event that appears to be required for 
the maintenance of Golgi structure.
Discussion
Although the late stages of ER–Golgi traffi  c have been visual-
ized by live cell imaging (Presley et al., 1997; Scales et al., 1997), 
Figure 6.  Cargo accumulates in structures that colocalize 
with COPII when mBet3p is inactivated in vivo. (A) The trafﬁ  ck-
ing of YFP-tagged tsO45 VSV-G to the cell surface was quan-
titated in HeLa cells that were microinjected with α-mBet3p or 
control IgG, as described in the Materials and methods. Error 
bars are the SD. (B) Intracellular trafﬁ   cking was monitored 
in BSC-1 cells that were injected with cDNA encoding CD8. 
After CD8 mRNA accumulated, the cells were injected with 
α-mBet3p or IgG. Subsequent to a 1-h incubation at 37°C, the 
cells were washed and the synthesis and transport of CD8 
was continued for 3 h. Finally, CD8 was chased for 45 min in 
the presence of cycloheximide. The cells were stained for 
CD8, Sec31p, or Golgin-84. To visualize Sec31p and Golgin-84, 
antibodies were directly conjugated to Alexa Fluor 594 
and viewed in the red channel. To visualize CD8, the second-
ary antibody was conjugated to Alexa Fluor 488 and viewed 
in the green channel. The inset shows the merge of CD8, 
Sec31p, and Golgin-84 in the α-mBet3p–injected cell. 
The merged image is on the right. Bar, 20 μm.COPII VESICLE TETHERING • YU ET AL. 365
little is known about the homotypic fusion of COPII   vesicles 
and how the pre-Golgi structure is formed from these vesicles. 
We provide evidence that mBet3p, the most highly conserved 
component of the TRAPP complex, plays a pivotal role in 
these events.
Although it was previously shown that the SNARE 
  syntaxin-5 is required for homotypic vesicle fusion (Xu and Hay, 
2004), the fi  ndings we report here are the fi  rst to link the tether 
TRAPP to VTC biogenesis. Our results imply that mBet3p is 
recruited to the tER region to mediate homotypic COPII vesicle 
tethering. Several lines of evidence support this proposal. First, 
we show that the localization of mBet3p is perturbed by condi-
tions that are known to alter or disrupt the tER, suggesting that 
mBet3p may be recruited to membranes by one or more compo-
nents of the tER. Second, mBet3p is required for homotypic 
COPII vesicle tethering in vitro and the inactivation of mBet3p 
in vivo leads to the accumulation of cargo in membranes that 
colocalize with the COPII subunit Sec31p. Finally, a role for 
mBet3p in VTC biogenesis is supported by data that shows the 
loss of mBet3p disrupts Golgi structure and the VTC marker 
ERGIC-53.
Immuno-EM revealed that mBet3p is enriched on more 
than one membrane, the tER region, and endosomal structures. 
Surprisingly, although yeast Bet3p was reported to reside on the 
Golgi (Sacher et al., 1998; Barrowman et al., 2000), we did not 
observe signifi  cant labeling of mBet3p on Golgi cisternae. 
In the yeast S. cerevisiae, tER, Golgi, and endosomal marker 
proteins are all found on punctate structures (Rossanese et al., 
1999). Yeast Bet3p was originally reported to reside on the 
Golgi because a signifi  cant fraction of the Bet3p containing 
puncta enlarged in a sec7 mutant (Sacher et al., 1998), a puta-
tive Golgi proliferating mutant (Novick et al., 1980). However, 
our more recent studies suggest that Sec7p and yeast TRAPPII 
(which contains Bet3p) may reside on endosomal membranes 
(Cai et al., 2005). The localization of mBet3p to both the tER 
region and endosomal structures is consistent with studies in 
Figure 7.  tER sites disperse and Golgi architecture is disrupted by perturbation of mBet3p. Western blot analysis revealed that siRNA targeted to mBet3p 
(BetC), but not luciferase, resulted in a decrease of mBet3p in COS-7 cells. (A) A >90% decrease of mBet3p, but not Sec31p or the ER protein ER60, was 
observed. Lane 1, mock-treated cells; lane 2, cells transfected with siRNA targeted to luciferase; lane 3, cells transfected with siRNA targeted to mBet3p. 
Similar results were obtained with BetA (not depicted) or BetC oligonucleotides. (B) The intense perinuclear localization of Sec31p is lost in cells depleted 
of mBet3p by RNAi. siRNA targeted to mBet3p (bottom) or luciferase as a control (top) were transfected into COS-7 cells. siRNA-transfected cells were 
stained with antibodies directed against mBet3p (left) and Sec31p (middle). The inset is magniﬁ  ed on the right. (C) The pre-Golgi compartment is disrupted 
in COS-7 cells transfected with mBet3-speciﬁ  c siRNA. siRNA targeted to luciferase (left) and mBet3 (right) were transfected into COS-7 cells and stained 
with α-mBet3p (top) and ERGIC-53 (bottom). (D) Golgi structure was disrupted in siRNA-treated HeLa cells that are depleted of mBet3p. EM analysis was 
performed on HeLa cells transfected with siRNA targeted to luciferase as a control (top) or mBet3p (BetC, bottom). The empty arrow points to a Golgi stack (top). 
Vesicles are marked with an arrow (bottom). The arrowhead marks a tubule (bottom). Mini Golgi stacks are labeled G (bottom). Bars: (B and C) 10 μm; 
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yeast showing that the two TRAPP complexes (TRAPPI and 
TRAPPII) act at different stages of membrane traffi  c.
Yeast TRAPPI, which contains Bet3p and several other 
subunits, is required for COPII vesicle tethering (Sacher et al., 
1998; Barrowman et al., 2000). Because it is diffi  cult to mor-
phologically distinguish membranes in the ER–Golgi branch of 
the yeast secretory pathway, no equivalent to a pre-Golgi com-
partment has been identifi  ed, and COPII vesicles are thought to 
tether directly to the Golgi. In mammalian cells, COPII vesicles 
do not fuse directly with the Golgi, instead it is thought they 
fuse with each other to form VTCs (Xu and Hay, 2004). The re-
cent fi  nding that the ER–Golgi intermediate compartment is 
stable (Ben-Takaya et al., 2005; Sannerud et al., 2006), how-
ever, has raised the possibility that homotypic fusion is not ex-
clusive and COPII vesicles may also heterotypically fuse with 
stable pre-Golgi membranes. Nonetheless, our in vitro and in 
vivo fi  ndings clearly show that mBet3p is required for the bio-
genesis of VTCs and Golgi membranes. The high degree of ho-
mology between yeast and mammalian Bet3p also raises the 
possibility that yeast COPII vesicles may undergo homotypic 
tethering and fusion before they fuse with the Golgi.  Elucidation 
of the mechanism of COPII vesicle tethering in yeast and mam-
malian cells will be needed to resolve this issue. In the future it 
will also be important to address how mammalian TRAPP me-
diates subsequent steps in membrane traffi  c. Experiments are 
currently in progress to address these questions.
Materials and methods
Antibodies
Monoclonal antibody directed against GM130 was purchased from BD 
Biosciences. CD8 antibody, monoclonal antibodies directed against the 
COPI coat (CM1A10), the lumenal domain of VSV-G protein, rodent Man 
II (53FC3), and Golgin-84 were obtained from G. Warren (Yale University, 
New Haven, CT). Monoclonal antibody directed against ERGIC-53 was 
obtained from H.-P. Hauri (University of Basel, Basel, Switzerland). Anti–
β-tubulin antibody (sc-5274) was purchased from Santa Cruz Biotechnology, 
Inc. Anti-ER60 antibody was obtained from P. Kim (University of Cincinnati, 
Cincinnati, OH). Monoclonal antibody directed against GalT (GTL-2) 
was obtained from D. Shima (Eyetech Research Center, Woburn, MA). 
Anti-Sec31p antibody (Shugrue et al., 1999) was obtained from F. Gorelick 
(Yale University, New Haven, CT), and polyclonal anti–Man II antibody 
was obtained from M. Farquhar (University of California, San Diego, 
San Diego, CA). Polyclonal rabbit anti-mBet3p antibody was previously de-
scribed (Sacher et al., 2000). Rabbit IgG speciﬁ  c to mBet3p was puriﬁ  ed 
on an Afﬁ  gel column (Bio-Rad Laboratories) preloaded with His6-tagged 
Bet3p. Bound IgG was eluted with 0.1 M glycine, pH 2.5. For immuno-
ﬂ   uorescence, ﬂ   uorescent-labeled secondary antibodies were purchased 
from Invitrogen.
Fluorescence microscopy
Cells grown on 10-mm coverslips were ﬁ  xed in cold methanol for 5 min (for 
GTL-2 and CM1A10 antibodies only), or ﬁ  xed in PBS with 3.7% formalde-
hyde for 15 min (for all other antibodies). Samples were quenched with 
  serum-free DME, rinsed with buffer A (PBS with 5 mM EDTA, 0.25% BSA, 
and 0.05% NP-40) and permeabilized with buffer B (PBS with 5 mM EDTA, 
0.25% BSA, 0.05% NP-40, and 0.1% Triton X-100) for 5 min. The samples 
were then treated with buffer C (PBS with 0.5% BSA) for 15 min.   Antibodies 
were applied, and the samples were incubated at room temperature 
for 1 h. After four washes in buffer C, the samples were incubated with 
secondary antibody for 30 min. Four additional washes were performed 
in buffer C, and the samples were mounted on glass slides in Fluoromount G 
(Southern Biotech). Images were taken with an Axiophot ﬂ   uorescence 
  microscope using a 63× oil-immersion objective and a LSM 510 confocal 
microscope (both from Carl Zeiss MicroImaging, Inc.). Images were cap-
tured with a digital camera Orca ER; Hamamatsu Photonics). The images 
were processed with the OpenLab 3.08 imaging software (Improvision) 
and Photoshop 7.0 (Adobe).
To deplete α-mBet3p of determinants directed against mBet3p, 
  afﬁ  nity-puriﬁ   ed antibody (1 μg/ml in buffer C) was incubated (with 
  agitation) for 2 h with a nitrocellulose strip containing 60 μg of puriﬁ  ed 
His6-tagged protein. Antibody was mock treated with a blank nitrocellulose 
strip as a control.
mBet3p was visualized with goat anti–rabbit secondary antibody con-
jugated to Cy3. GM130, COPI, β-tubulin, and ERGIC-53 were visualized 
with donkey anti–mouse secondary antibody conjugated to FITC. For double-
labeling experiments with mBet3p and Sec31p, the Zenon labeling kit was 
used (Invitrogen). Samples were ﬁ  rst stained with α-mBet3p and then stained 
for Sec31p, using this kit according to the manufacturer’s instructions.
Microinjection experiments
Afﬁ  nity-puriﬁ  ed α-mBet3p, control IgG, or Sar1p
DN was injected into COS-7 
or NRK cells as previously described (Seemann et al., 2000a). The antibody- 
injected samples were ﬁ  xed and stained after 2 h, whereas the Sar1p
DN-
  injected samples were ﬁ  xed and stained after 6 h.
Homotypic COPII vesicle tethering/fusion assay
Experiments were performed as previously described (Xu and Hay, 2004). 
The VSV-G–Myc–expressing cells and the pulse-radiolabeled VSV-G*–
  containing cells were permeabilized by scraping the cells. For the ﬁ  rst-stage 
incubation, each reaction was 1,595 μl and contained 352 μl of water, 
55 μl of 0.1 M magnesium acetate, 110 μl of an ATP-regenerating system, 
33 μl of 1 M Hepes, pH 7.2, 220 μl of 20/18/50 buffer (20 mM Hepes, 
pH 7.2, 18 mM CaCl2, and 50 mM EGTA), 550 μl of rat liver cytosol dia-
lyzed into 25/125 buffer (25 mM Hepes, pH 7.2, and 125 mM potassium 
acetate), and 275 μl of either semi-intact NRK cell population. Reactions 
were incubated at 32°C for 30 min (stage I incubation), centrifuged at 
4,000 g for 1 min, and then centrifuged again at 15,000 g for 1 min. The 
supernatant, which contained the vesicles, was saved. In the stage II incu-
bation, each reaction was 200 μl and contained 72.5 μl of VSV-G–Myc 
vesicles, 72.5 μl of VSV-G* vesicles, and 55 μl of 25/125 buffer or puri-
ﬁ  ed proteins (antibodies, GST, or GST-Sec23p) dissolved in 25/125 buffer. 
After a 20-min preincubation on ice, the reactions were incubated at 32°C 
for 60 min (stage II incubation). For coisolation assays, the ﬁ  nal intact vesi-
cle suspensions were processed for immunoisolation using biotinylated 
anti-Myc antibodies and streptavidin–Sepharose. Bound vesicles were ana-
lyzed by SDS-PAGE (8%) and autoradiography, and the coisolated 
VSV-G* was quantiﬁ  ed. For heterotrimer assays, the ﬁ  nal vesicle suspen-
sions were incubated with 2% Triton X-100 for 20 min and then centrifuged 
at 100,000 g for 30 min. The 100,000 g supernatants containing solubi-
lized VSV-G trimers were then processed for immunoprecipitation using 
biotinylated anti-Myc antibody and streptavidin–Sepharose, and the 
  co  precipitating VSV-G* was quantiﬁ  ed.
Trafﬁ cking assays
VSV-G transport was assayed as previously described (Diao et al., 
2003) with several minor exceptions. HeLa cells were ﬁ  rst injected with 
1.5 mg/ml α-mBet3p or 1.5 mg/ml control IgG; 2 h later, plasmid encod-
ing 0.2 mg/ml YFP-tagged tsO45 VSV-G was injected. Protein transported 
to the cell surface was detected with a monoclonal antibody to the lumenal 
domain of VSV-G that was conjugated to Alexa Fluor 647. Total VSV-G 
was detected by YFP. The extent of VSV-G transport to the cell surface was 
determined by the ratio of surface to total measured ﬂ  uorescence, as previ-
ously described (Seemann et al., 2000b). A total of nine cells injected with 
either α-mBet3p antibody or IgG were quantitated. The trafﬁ  cking of the 
plasma membrane marker CD8 was monitored, as previously described 
(Pelletier et al., 2000). Cells were injected with 1.5 mg/ml α-mBet3p or 
1.5 mg/ml IgG after the CD8 plasmid was injected in the presence of 
100 μg/ml cycloheximide. The incubation was then continued for 1 h 
at 37°C.
RNAi
siRNA oligonucleotides speciﬁ  c for human Bet3p were designed   according 
to the method developed by Dharmacon Research, Inc. Two oligonucleotides, 
BetA (5′-U  C  A  C  U  C  C  A  A  G  C  A  U  U  A  C  U  A  A  U  U  -3′) and BetC (5′-G  G  A  G  A  C  G-
G  U  G  U  G  A  C  A  G  A  A  A  U  U  -3′) were chosen because they are speciﬁ  c  and 
  target to regions that are conserved between human and monkey Bet3 
  sequences. Duplex RNA was introduced into COS-7 or HeLa cells, using 
OligofectAMINE (Invitrogen) according to the manufacturer’s instructions. 
3 d after transfection, the cells were analyzed. In three independent experi-
ments, the reduction of mBet3p (determined by Western blot analysis) COPII VESICLE TETHERING • YU ET AL. 367
ranged from 74 to 99% using BetA, and from 87 to 99% for BetC. 
Samples were quantitated using Image 1.61/68 K software (National 
  Institutes of Health, Bethesda, MD).
EM analysis
Immuno-EM was performed in NRK cells as previously described (Folsch 
et al., 2003). Estimation of labeling densities was determined on digital 
images captured using a charge-coupled device camera (Morada; Soft Im-
aging System). At a magniﬁ  cation of 43,000×, sections were scanned 
and 118 ﬁ  elds were captured at random. Transitional elements were de-
ﬁ  ned as tubular vesicular clusters found in the proximity of ER membranes 
labeled for Sec31p (at least two gold particles). The labeling density for 
mBet3p was calculated by counting the number of 5-nm gold particles fall-
ing on or within 15 nm of membranes, and dividing these numbers by the 
length of the membranes expressed in micrometers. Length was estimated 
by counting the number of intersections of membranes with the vertical and 
horizontal lines of a grid at an estimated distance of 110 nm between lines 
(Weibel and Bolender, 1979).
HeLa cells were processed for EM analysis as previously described 
(Lopez et al., 2002), with the following two exceptions: cells were scraped 
after ﬁ  xation, and the section thickness was 60 nm. Quantitation of Golgi 
membrane was done directly at the EM. Sections were scanned horizon-
tally in a random fashion at a magniﬁ  cation of 9,900×, and the number 
of intersections of membrane with a ﬁ  xed point were counted. For each 
sample, >900 intersections with the plasma membrane were counted. The 
number of intersections with stacked Golgi cisternae was divided by the 
number of intersections with the plasma membrane (or nuclear envelope). 
A threefold decrease in the ratio of Golgi to plasma membrane (or Golgi 
to nuclear envelope) was observed in the mBet3p-depleted sample. HeLa 
cells were used for this analysis because it was easier to obtain better cryo-
sections with these cells than with COS-7 cells.
Online supplemental material
Figure S1 shows a still from Video 1. Fig. S2 shows that the loss of mBet3p 
blocks COPII vesicle tethering and disrupts Golgi architecture. Fig. S3 
shows that microinjected α-mBet3p, but not control IgG, disrupts the pre-
Golgi compartment marked by ERGIC-53 in COS-7 cells. Fig. S4 shows 
the rough ER is highly dilated in siRNA-treated mBet3p-depleted HeLa cells. 
Video 1 shows the colocalization of mBet3p and Sec31p in nocodazole-
treated cells. Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.200603044/DC1.
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